According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

Accurate RNA splicing is essential for gene expression and human health, yet predicting how DNA sequence variations affect ...

At Baylor Genetics, we believe the biggest leap forward for rare disease diagnosis will happen when WGS becomes the standard ...

Colossal Biosciences is working with the U.S. Fish and Wildlife Service to launch a biobank to save endangered species.

Silver nanoparticles provide a more efficient way to cut and assemble DNA, improving recovery rates and boosting DNA joining ...

How diseases develop and how the body ages can differ between females and males, but the biological reasons for these differences are not fully understood. Researchers are studying the role of sex ...

Many repetitive regions of the genome have been considered "junk DNA" because the available technologies did not allow them to be studied at sufficient resolution. This is the case for the SST1/NBL2 ...

Scientists at Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered that large pieces of DNA can transfer directly between human cells, and the DNA can persist and ...

The DNA diagnostics market is experiencing robust growth, driven by the increasing prevalence of genetic disorders, infectious diseases, and cancer worldwide. Rising adoption of precision medicine ...

Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s DeepMind now claims to have found a revolutionary use case for AI: helping ...

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery. By Carl Zimmer In 2024, two scientists from Google DeepMind ...